GlassScriptPhysician profile
Itzel Ibarra
NPI 1174180749
$944.68
in general payments reported to CMS, 2019-2025
17 companies · $89.12 in 2025
The $89.12 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.96 · 2022: $561 · 2023: $131 · 2024: $66.89 · 2025: $89.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $178.72 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $165.69 | 2022-2024 | Farxiga |
| Novo Nordisk INC | $155.87 | 2021-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $146.50 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $85.89 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $29.20 | 2023 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.36 | 2025 | Xifaxan |
| Esperion Therapeutics, INC. | $21.63 | 2021 | |
| Amarin Pharma, INC. | $18.42 | 2022 | |
| Merck Sharp & Dohme LLC | $17.84 | 2022 | |
| Abbvie INC. | $17.31 | 2022 | |
| Astellas Pharma US INC | $16.68 | 2022 | |
| Dexcom, INC. | $16.37 | 2022 | |
| Electromed, INC. | $15.14 | 2023 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.90 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $12.53 | 2021 | |
| Genentech USA, INC. | $10.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itzel Ibarra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.